Breast Intraductal Proliferative Lesion

Breast Intraductal Proliferative Lesion — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03323658	Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer	completed	Phase 1	24	National Cancer Institute (NCI)NIH	1	Jan 10, 2023	clinicaltrials
NCT00637481	A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer	completed	Phase 1	66	National Cancer Institute (NCI)NIH	1	Dec 29, 2016	clinicaltrials
NCT01372644	Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial	completed	Phase 1	15	NYU Langone HealthOTHER	1	Dec 5, 2016	clinicaltrials

Data updated 23 days agoSource updated Jan 10, 2023source: clinicaltrials